
Current Price | $98.13 | Mkt Cap | $195.6B |
---|---|---|---|
Open | $97.66 | P/E Ratio | 27.17 |
Prev. Close | $98.13 | Div. (Yield) | $3.50 (2.3%) |
Daily Range | $97.55 - $98.32 | Volume | 511 |
52-Wk Range | $75.71 - $99.98 | Avg. Daily Vol. | 1,491,795 |
Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.
Current Price | $98.13 | Mkt Cap | $195.6B |
---|---|---|---|
Open | $97.66 | P/E Ratio | 27.17 |
Prev. Close | $98.13 | Div. (Yield) | $3.50 (2.3%) |
Daily Range | $97.55 - $98.32 | Volume | 511 |
52-Wk Range | $75.71 - $99.98 | Avg. Daily Vol. | 1,491,795 |
The best Bull and Bear pitches based on recency and number of recommendations.
Dividend, M & A activity, and pipeline.
After a good run in the past couple months, NVS looks poised to underperform the S&P. Not that I think its going to take a fall, more so that the S&P will be playing catchup for the next couple of months while NVS hangs around somewhat.
Read the most recent pitches from players about NVS.
Recs
https://www.luf.org
Recs
Under-priced stock with a strong portfolio and increased revenue.
Recs
Novartis has numerous fast-growing drugs, which is why analysts are expecting 8% annual earnings growth over the next five years. At just 13 times this year's earnings, Novartis is reasonably priced. That's why I expect the stock will outperform the S&P 500 in the next 5-10 years.
Find the members with the highest scoring picks in NVS.
Bankwatcher1 (22.76) Score: +160.93
The Score Leader is the player with the highest score across all their picks in NVS.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
Bankwatcher1 | 22.76 | 10/7/2008 |
![]() |
NS | $34.41 | +184.93% | +345.87% | +160.93 | 0 Comment | |
Spelunkin | 27.63 | 11/2/2009 |
![]() |
5Y | $34.76 | +182.08% | +340.89% | +158.81 | 0 Comment | |
PurePwnage | 95.99 | 11/27/2009 |
![]() |
5Y | $36.87 | +165.95% | +323.52% | +157.57 | 0 Comment | |
39272x0 | 28.63 | 12/2/2009 |
![]() |
5Y | $37.81 | +159.34% | +312.56% | +153.23 | 0 Comment | |
kaChingkaChing | 34.29 | 12/2/2009 |
![]() |
3W | $37.81 | +159.34% | +312.56% | +153.23 | 0 Comment | |
TrackDuality | < 20 | 11/6/2009 |
![]() |
5Y | $35.14 | +179.06% | +332.05% | +152.99 | 0 Comment | |
DiamondDawg | 91.24 | 11/25/2009 |
![]() |
5Y | $37.47 | +161.66% | +312.97% | +151.31 | 0 Comment | |
39272x4 | 23.69 | 11/10/2009 |
![]() |
5Y | $35.95 | +172.75% | +320.00% | +147.24 | 0 Comment | |
wcwhiner | 27.14 | 4/28/2009 |
![]() |
NS | $24.92 | +293.41% | +439.51% | +146.10 | 0 Comment | |
BridgeTech | < 20 | 5/29/2009 |
![]() |
3Y | $26.82 | +265.54% | +407.45% | +141.91 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.